Sort by
Refine Your Search
-
with a background in hormone-driven cancers to join a dynamic and fast-paced discovery biology team. The successful candidate will join the Oncogene & Cancer Vulnerabilities group embedded within
-
, high-content/high-throughput screening, molecular biology, and complex cellular models, to support and accelerate the deconvolution of novel therapeutic mechanisms across a diverse discovery portfolio
-
technology development Hands on experience in mRNA synthesis, purification, characterization, and translational profiling Strong understanding of RNA biology and modeling for RNA folding and RNA-protein
-
datasets generated from omics experiments to drive drug discovery and development. The role will require applying a deep understanding of biology together with advanced computational methods to solve complex
-
basic discoveries in the field of cancer cell biology into novel therapeutics. The Senior Scientist will work within a collaborative team of motivated and scientifically rigorous scientists to conduct
-
to the clinic Utilize expertise in epigenetic biology to develop innovative strategies for understanding role of epigenetic mechanisms in cancer progression, drug resistance and immune modulation Collaborate with
-
Laboratory Practices (GCLP) requirements. Develop assays or animal models required to support various vaccine projects. Develop tool assets for advancing systems biology group projects including cell models
-
, Chemical Biology, or related discipline OR M.S. degree in Chemistry, Biochemistry, Chemical Biology, or related discipline with minimum 7 years experience, with 3 of those years in the biopharmaceutical
-
knowledge of scientific trends and new technologies. QUALIFICATIONS Must Have Bachelor's degree with 9+ years of experience, or master's degree with 6+ years of experience in molecular biology, biochemistry
-
, including Structural Biology, Chemical Biology, Primary Pharmacology, and Pharmacokinetics and Drug Metabolism, to ensure the delivery of small-molecule/synthetic drug candidates with scientific excellence